BackTrxade Health Overview

Trxade Health Inventory

Track Trxade Health's inventory ($210M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$210.93M

Peer trimmed avg / median

Loading

Trxade Health Inventory History

Loading

Trxade Health vs. peers: Inventory Comparison

Loading

Trxade Health Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Trxade Health (MEDS) FAQ

Trxade Health (MEDS) currently reports a inventory of $210M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Trxade Health's inventory history and peer comparisons.

Trxade Health's inventory changed from $0 to $210M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trxade Health reported $210M in inventory as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Trxade Health, and consider following MEDS for alerts when major investors trade the stock.

Trxade Health is classified in the Finance sector. On inventory, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing MEDS with unrelated industries.